Chiesi has signed a strategic deal with StartUp Health, a global health innovation company focused on achieving Health Moonshots. StartUp Health has the largest digital health-focused portfolio in the world, consisting of over 235 companies applying technology to solve key challenges such as creating global access to care, reducing cost and curing disease.
With this achievement, Chiesi completes its first strategic deal in the technology space.
This partnership with StartUp Health is a significant step forward in Chiesi’s technology & digital health strategy. Chiesi plans to combine its deep expertise in respiratory care, neonatology, special care and rare diseases with StartUp Health’s extensive global network of innovative companies and partners, stimulating research and the availability of therapeutic solutions for our patients.
“Partnerships, acquisitions and collaborations in Chiesi are pivotal to create long-term value for the organization,” commented Giacomo Chiesi, Head of Global Corporate Development. “This partnership is an example of our strategy to combine digital innovations, disease management and patient care with therapeutic options. Our team is working on additional deals in the digital and technology space which we hope will come to fruition in 2018.”
StartUp Health is a global organization focused improving health and wellbeing worldwide by leveraging the latest advancements in the digital health ecosystem. In 2011, StartUp Health introduced a revolutionary new model for transforming health by organizing and supporting a global army of entrepreneurs called Health Transformers™. The Company is investing in 10 Health Moonshots, with the long-term goal of improving the health and wellbeing of everyone in the world. StartUp Health has the world’s largest digital health portfolio (over 235 companies spanning the globe). Founded by Steven Krein and Unity Stoakes, StartUp Health is chaired by former Time Warner CEO Jerry Levin. Notable strategic partners and investors include Allianz, Aurora Health Care, Bayer, California Health Care Foundation, Chiesi Farmaceutici S.p.A, Steve Case, Mark Cuban, Esther Dyson, Brad Feld, Genentech, GE Ventures, GuideWell, Kaiser Permanente Ventures, Masimo Corporation, Ping An, SAP, and SeventySix Capital.